REFERENCES Medical Assignment Help

REFERENCES
1. Grisius M: Salivary gland dysfunction: a review of systemic
therapies, Oral Surg Oral Med Oral PathoI92:1S6, 2001.
2. Khan Z,Jacobsen CS:Oral pilocarpine HCI’fOl:post-irradiation
xerostomia in head and neck cancer patients. In Proceedings
of the First International Congress on Max.illof(l~ial Prosthetics,
New York, 1995, Memorial Sloan-Kettering Cancer
Center.
41 6 PART IV • Infections
3. 5pijkervet FJ(: Irradiation mucositis, Copenhagen, 1991,
Mun-ksgaarC1.
4. Spljkervet FJ<et al: Effect of selective elimination of the oral
. flora on mucositis in trIadlated head and neck cancer
patients,’ Surg OncoI46:167, 199,1. .
5. Matheis }.oQ et al: Evaluation’ df oral mucositis In patients
receiving radiation therapy for head and neck cancer: a pilot
study of 0.12% chlorhexldine gluconate .oral hose. In Pr0-
ceedings of the First International Congress on MaxillofaCial Prosthetics,
New York, 1995, Memorial Sloan-Kettering Cancer
Center., ‘
6. FerrettiGAet al: ChlorheXIdineprophylaXisforchemotherapyand
radiation-induced stomatitis: a randomized doubleblind
trial, aral Surg Oral Med Oral Pathol 70:331, 1990.
7. Beumer J. Brady F: Dental management of the irradiated
patient, Int’ Oral Surg 7:208, 1978.
8. BeumerJ. Curtts T, Harrison RE:Radiation therapy of the oral
cavity. I. Sequelae and management, Head Neck Surg 1:301,
1979. ,
9. BeumerJ, Curtis T, Harrison RE:Radiation therapy of the oral’
cavity. II. Sequelae and management, Head Neck Surg 1:392,
1979. ‘
10.. Beumer J, Curtis TA,Morrish RB:Radiation complications in
edentulous patients” Prosthet Dent 36:193, 1976.
11. Driezen S et al: Prevention of xerostomia-related dental
cartes in irradiated cancer psttents, l Dent Res 56:99, 1977.
12. Bedwinek JM et al: Osteonecrosts in patients treated with
definitive radiotherapy for squamous cell carcinomas of the
oral cavity and naso and oropharynx, Radiology 119:665,
1976.
13. Starcke EN, Shannon IL:How critical is the Interval between
extractions and irradiation in patients with head and neck
malignancy? Oral Surg 43:333, 1977. ‘ .
14. Marx RE: A new concept in the treatment of osteoradionecrosis,
,Oral Maxillofac Surg 41:351,1983.
15. Marx RE: Osteoradionecrosis: a new concept in Its pathophystology,
Oral Maxillofac Surg 4.1:283, 1983.
16. Marx RE, Johnson RP, J<1ine SN: Prevention of osteoradionecrosis:
a randomized prospective clinical trial of hyperbaric
oxygen versus penidllm, Am Dent Assoc 111:49,1985.
17’. Hobo 5, Ichlda E, Garcia LT:Osseointegration and occlusal rehabilitation,
Tokyo, 1989, Quintessence. ‘
18. Granstrom G et al: Bone-anchored reconstruction of the Irra-
, diated head and neck cancer ‘patient, Otolaryngo; Head Neck
: Surg 108:334, 1993.
“‘” . ‘t.
, .
19. Vlsch LL, Levendag PC, Denlssen JiW: Five-year results of
227 HA-coated Implants in irradiated tissues. In Proceedings
of the First International Congress on Maxillofadal Prosthetics,
New York, 1995, Memorial Sloan-Kettermg Cancer Center.
20. Granstrom G, Iacobsson M, Tjellstrorn A:Titanium implants
in the Irradiated tissue. Benefits from hyperbaric oxygen, 1m
,Oral Maxillofac Implants 7:15, 1992.
21. Albrektsson T: A multicenter report on osseointegrated oral
implants,’ Ptosthet Dent 60:75, 1988.
22. TaylorTO, Worthington P: Osseointegrated implant rehabilitation
of the previously irradiated mandible: results of a limitedtrial
at 3 to 7 years, , Prosthet Dent 69:60, 1993.
23. Beumer J et al: Postradiation dental extractions: a review of
the literature and a report of 72 episodes, Head Neck Surg .
6:581, i983.
24. Murray CG et al; Radiation necrosis of the mandible: a
10-year study. I. Factors influencing the onset of necrosis, 1m
, Rqdiat Oncol BioI Phys 6:543, 1980.
25. Murray CG et al: Radiation necrosis of the mandible: a
10-year study. II, Dental factors: onset, duration, and management
of necrosis, Int I Radiat Oneol Bioi Phys 6:549, 1980.
26. Greenberg MS et al: Tl)e oral flora as a source of septicemia
in patients with acute leukemia, Oral Surg 53:32, 1~82.
27. McElroy TIf: Infection in the patient receiving chemotherapy:
oral considerations, , Am Dent Assoc 109:454, 1984.
28. Epstein JB: Antifungal therapy in oropharyngeal mycotic
infections, Oral Surg 69:32, 1990. ‘
29. Heimdahl A, Nord CE: Oral yeast Infections In Immunocompromised
and seriously diseased patients, Acta Odontol
Scand 48;77, 1990.
30. Odds FC et al: Carriage, of Candida species and C. albicans
, blotypes In patients undergoing chemotherapy or bone marrow
transplantation for haematological disease, l Clin Patho!
42:1259, 1989.
31. DePaola LG et al: Dental care for, patients receiving
chemotherapy, I Am Dent Assoc 112:198, 1986.
32. Wright WE et al: An oral disease prevention program for
patients receiving radiation and chemotherapy, , Am Dent
Assoc 110:43, 1985.
33. Thurmond JM et al: Oral Candida albicans in bone marrow
transplant patients given chlorhexldine ‘rinses: occurrence
and susceptibilities to the agent, Oral Surg 72:291, 1991

Posted by: brianna